Try one of the below options to narrow down your search.
 |
Documents may be browsed by date, eg; Today, May, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term:
2010 / 09 / 30
PHARMAC documents that matched your search:
2010-02 Respiratory Subcommittee Minutes
(8 pages, 51 KB)
2010/09/30
Respiratory Subcommittee of PTAC meeting held 5 February 2010 (minutes for web publishing) Respiratory Subcommittee minutes are published in accordance with the Terms of Reference for the Pharmacology and Therapeutics Advisory Committee (PTAC) and PTAC Subcommittees 2008. Note that this…
2010-03 Transplant Immunosuppressant Subcommittee Minutes
(2 pages, 16 KB)
2010/09/30
Transplant Immunosuppressant Subcommittee of PTAC meeting held 16 March 2010 (minutes for web publishing) Transplant Immunosuppressant Subcommittee minutes are published in accordance with the Terms of Reference for the Pharmacology and Therapeutics Advisory Committee (PTAC) and PTAC Subcommittees 2008. Note…
2010-05 Pulmonary Arterial Hypertension Subcommittee Minutes
(6 pages, 34 KB)
2010/09/30
Pulmonary Arterial Hypertension Subcommittee of PTAC meeting held 13 May 2010 (minutes for web publishing) Pulmonary Arterial Hypertension Subcommittee minutes are published in accordance with the Terms of Reference for the Pharmacology and Therapeutics Advisory Committee (PTAC) and PTAC Subcommittees…
2010-06 Mental Health Subcommittee Minutes
(8 pages, 41 KB)
2010/09/30
Mental Health Subcommittee of PTAC meeting held 21 June 2010 (minutes for web publishing) Mental Health Subcommittee minutes are published in accordance with the Terms of Reference for the Pharmacology and Therapeutics Advisory Committee (PTAC) and PTAC Subcommittees 2008. Note…
Consultation on a proposal with InterPharma for various oncology products.; Closing Date: Closed; Contact: Sue Anne Yee
(5 pages, 136 KB)
2010/09/30
30 September 2010 Proposal relating to calcium folinate, methotrexate, paclitaxel, epirubicin, carboplatin, oxaliplatin and fludarabine Following a request to pharmaceutical suppliers for commercial proposals as an alternative to tendering certain pharmaceuticals for sole supply, PHARMAC and InterPharma Pty Limited have…
Consultation on changes to sildenafil PAH criteria. ; Closing Date: Closed; Contact: Stephen Woodruffe
(3 pages, 48 KB)
2010/09/30
30 September 2010 Proposal to amend the access criteria for Pulmonary Arterial Hypertension treatments PHARMAC is seeking feedback on a proposal to widen the pulmonary arterial hypertension (PAH) funding criteria. In summary, this proposal would result in (with effect from…
Price increase for Pfizer daunorubicin.
(1 page, 98 KB)
2010/09/30
30 September 2010 Price increase for Pfizer Daunorubicin PHARMAC is pleased to announce the approval of an agreement with Pfizer for daunorubicin. In summary, the effect of the decision is that the Pfizer brand of daunorubicin 2mg/ml, 10 ml will…
Proposal for rivaroxaban, moxifloxacin, interferon beta-1-beta and other MS Treatments. Closed
(5 pages, 64 KB)
2010/09/30
30 September 2010 Proposal for rivaroxaban, moxifloxacin, interferon beta-1-beta and other funded treatments for multiple sclerosis PHARMAC is seeking feedback on a provisional agreement with Bayer New Zealand Limited to: • fund rivaroxaban (Xarelto), a new agent for the prophylaxis…
Proposed PAH eligibility form.
(27 pages, 145 KB)
2010/09/30
ELIGIBILITY CRITERIA FOR PULMONARY ARTERIAL HYPERTENSION THERAPY Contents ELIGIBILITY CRITERIA FOR INITIATION OF PULMONARY ARTERIAL HYPERTENSION THERAPY …..2 Initial Application for Funding of Pulmonary Arterial Hypertension Treatments for Adults (and children aged over 10 years)….7 Renewal Application / Request for…
September Tender Notification.
(2 pages, 42 KB)
2010/09/30
30 September 2010 TENDER RESULTS The PHARMAC Board (or Chief Executive under delegated authority) has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2009/10 Invitation to Tender, dated 4…
